Key facts
- This page summarizes John C. Thomas's Form 5 filing for ImmunityBio, Inc. (IBRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Jan 2022, 15:29.
John C. Thomas - 31 Dec 2021 Form 5 Insider Report for ImmunityBio, Inc. (IBRX)
- Reporting relationship
- Former Director
- Issuer ticker
- IBRX
- Reported as of
- 31 Dec 2021
- Net transaction value
- $0
- SEC form
- 5
- Accepted by SEC
- 28 Jan 2022, 15:29:28 UTC
- Prior SEC filing
- 23 Jun 2021
- Next SEC filing
- 04 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Steven Yang, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John C. Thomas filed Form 5 for ImmunityBio, Inc. (IBRX) on 28 Jan 2022.
Change
- Previous filing in this sequence was filed on 23 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 5 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IBRX
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -5,000
- Change %
- -2.4%
- Price
- $0.000000
- Shares after
- 202,477
- Date
- 23 Feb 2021
- Ownership
- Direct
IBRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,886
- Date
- 31 Dec 2021
- Ownership
- See footnote
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
John C. Thomas is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96.